Loading...
Thermo Fisher Scientific Inc.
TMO•NYSE
Healthcare
Medical - Diagnostics & Research
$397.89
$5.33(1.36%)
Thermo Fisher Scientific Inc. (TMO) Financial Performance & Statements
Review Thermo Fisher Scientific Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.05%
↑ 0.05%
Operating Income Growth
6.97%
↑ 6.97%
Net Income Growth
5.67%
↑ 5.67%
Operating Cash Flow Growth
3.10%
↑ 3.10%
Operating Margin
17.08%
↑ 17.08%
Gross Margin
41.57%
↑ 41.57%
Net Profit Margin
15.19%
↑ 15.19%
ROE
13.34%
↑ 13.34%
ROIC
8.53%
↑ 8.53%
Thermo Fisher Scientific Inc. (TMO) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Thermo Fisher Scientific Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $11.39B | $10.60B | $10.54B | $10.35B |
| Cost of Revenue | $6.49B | $6.27B | $6.20B | $6.13B |
| Gross Profit | $4.90B | $4.33B | $4.34B | $4.22B |
| Gross Profit Ratio | $0.43 | $0.41 | $0.41 | $0.41 |
| R&D Expenses | $374.00M | $346.00M | $339.00M | $331.00M |
| SG&A Expenses | $1.85B | $2.10B | $2.25B | $2.17B |
| Operating Expenses | $2.89B | $2.49B | $2.59B | $2.50B |
| Total Costs & Expenses | $9.38B | $8.76B | $8.78B | $8.63B |
| Interest Income | $227.00M | $277.00M | $295.00M | $279.00M |
| Interest Expense | $317.00M | $356.00M | $354.00M | $363.00M |
| Depreciation & Amortization | $742.00M | $740.00M | $790.00M | $836.00M |
| EBITDA | $3.00B | $2.91B | $2.98B | $2.56B |
| EBITDA Ratio | $0.26 | $0.27 | $0.28 | $0.25 |
| Operating Income | $2.02B | $1.84B | $1.76B | $1.72B |
| Operating Income Ratio | $0.18 | $0.17 | $0.17 | $0.17 |
| Other Income/Expenses (Net) | -$75.00M | -$96.00M | -$55.00M | -$74.00M |
| Income Before Tax | $1.94B | $1.74B | $1.76B | $1.59B |
| Income Before Tax Ratio | $0.17 | $0.16 | $0.17 | $0.15 |
| Income Tax Expense | $150.00M | $99.00M | $128.00M | $281.00M |
| Net Income | $1.83B | $1.63B | $1.55B | $1.33B |
| Net Income Ratio | $0.16 | $0.15 | $0.15 | $0.13 |
| EPS | $4.79 | $4.27 | $4.05 | $3.48 |
| Diluted EPS | $4.78 | $4.24 | $4.04 | $3.46 |
| Weighted Avg Shares Outstanding | $382.85M | $382.00M | $382.00M | $382.00M |
| Weighted Avg Shares Outstanding (Diluted) | $383.00M | $384.00M | $383.00M | $384.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan